Here at Bioperfectus we innovate our products by considering for our end-users.
To meet with various testing demands in different clinical laboratories, Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test...
Bioperfectus have gotten an update from RUSSIAN FEDERAL SERVICE FOR SURVEILLANCE IN HEALTH CARE
No one should suffer, especially are children.
There are approximately 68 million people in the U.S. had an STI every day in 2018...
Bioperfectus Novel Corona Virus (SARS-CoV-2) IgG/IgM Rapid Test Kit has been granted a Brazil ANVISA Registration.
Antigen tests can be used in a variety of testing strategies to respond to the COVID-19 pandemic.
Bioperfectus is pleased to invite you to join us for Bioperfectus 1st Distributors Conference & New Product Launch 2021.
Bioperfectus donates 6,000 pieces of new coronavirus nucleic acid test kits to Sister cities in Italy and Netherlands
Bioperfectus Aid Materials Greatly Enhancing Guyana's Local Testing Capabilities
